RESMED INC. DL-,004/ US7611521078 /
21/06/2024 09:44:25 | Chg. +0.300 | Volume | Bid10:05:15 | Ask10:05:15 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
199.950EUR | +0.15% | 30 Turnover: 5,998.500 |
198.650Bid Size: 50 | 200.500Ask Size: 50 | 29.27 bill.EUR | - | - |
GlobeNewswire
10/06
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep A...
GlobeNewswire
23/05
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
16/05
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
16/05
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
07/05
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
GlobeNewswire
10/04
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH
GlobeNewswire
06/03
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Per...
GlobeNewswire
05/03
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
GlobeNewswire
15/02
ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communi...
GlobeNewswire
12/02
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions abo...
GlobeNewswire
06/02
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth...